Zobowiązania Handlowe Zmiana Data
AstraZeneca USD 22.89B 388M 2026-06
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 14.34B 7M 2026-06
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Qiagen NV USD 78.3M 5.64M 2026-03
UCB EUR 4.04B 755M 2025-12